Synlogic Inc (SYBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Synlogic Inc (SYBX) has a cash flow conversion efficiency ratio of -0.078x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-923.00K) by net assets ($11.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Synlogic Inc fund operations to measure how many days the company can operate on defensive assets alone.
Synlogic Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Synlogic Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Synlogic Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Synlogic Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Adcore Inc
TO:ADCO
|
0.406x |
|
Straits Inter Logistics Bhd
KLSE:0080
|
0.211x |
|
Lekoil Limited
F:L5K
|
0.029x |
|
Worksport Ltd
NASDAQ:WKSP
|
-0.412x |
|
Lombard et Medot SA
PA:MLCAC
|
N/A |
|
Mcnally Bharat Engineering Company Limited
NSE:MBECL
|
0.000x |
|
Vital Energy Inc
V:VUX
|
0.110x |
|
DEFSEC Technologies Inc.
NASDAQ:DFSC
|
-0.430x |
Annual Cash Flow Conversion Efficiency for Synlogic Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Synlogic Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Synlogic Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $11.86 Million | $-4.36 Million | -0.367x | +85.20% |
| 2024-12-31 | $12.75 Million | $-31.66 Million | -2.483x | -105.18% |
| 2023-12-31 | $42.66 Million | $-51.61 Million | -1.210x | -75.72% |
| 2022-12-31 | $82.61 Million | $-56.89 Million | -0.689x | -94.28% |
| 2021-12-31 | $147.27 Million | $-52.20 Million | -0.354x | -3.18% |
| 2020-12-31 | $115.14 Million | $-39.55 Million | -0.344x | +28.58% |
| 2019-12-31 | $156.91 Million | $-75.47 Million | -0.481x | -40.54% |
| 2018-12-31 | $124.10 Million | $-42.47 Million | -0.342x | +6.29% |
| 2017-12-31 | $85.04 Million | $-31.05 Million | -0.365x | +11.15% |
| 2016-12-31 | $60.35 Million | $-24.80 Million | -0.411x | -65.33% |
| 2015-12-31 | $85.02 Million | $-21.14 Million | -0.249x | -185.33% |
| 2014-12-31 | $-47.95 Million | $-13.97 Million | 0.291x | +34.16% |
| 2013-12-31 | $-29.91 Million | $-6.50 Million | 0.217x | -- |
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.